Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034
The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.
The disease primarily affects middle-aged women and has a poor long-term prognosis despite therapeutic advances.